Cloud Banner

Healthcare

Image

Global Maraburg Hemorrhagic Fever Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Sep 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Maraburg Hemorrhagic Fever Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 5.5% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 90.74 Million
Diagram Market Size (Forecast Year) USD 139.25 Million
Diagram CAGR 5.5%

Global Maraburg Hemorrhagic Fever Market, By Drug Classification (Antiemetic, Nitroglycerin, Loperamide, Antibiotics, Others), Route of Administration (Injectable, Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Ambulatory Surgical Centers, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.

Maraburg Hemorrhagic Fever Market

Maraburg Hemorrhagic Fever Market Analysis and Size          

Marburg virus refer to the type of virus that belongs to the genus marburgvirus in the family filoviridae. This virus causes a severe hemorrhagic fever that is known as global marburg hemorrhagic fever (MHF), in both humans and nonhuman primates. MHF is generally characterized by systemic viral replication, abnormal inflammatory responses and immunosuppression, similar to Ebola hemorrhagic fever. The surge in the number of people suffering from marburg hemorrhagic fever across the globe acts as one of the major factors driving the growth of global marburg hemorrhagic fever market.

Data Bridge Market Research analyses that the global maraburg hemorrhagic fever market which was USD 90.74 million in 2022, would rocket up to USD 139.25 million by 2030, and is expected to undergo a CAGR of 5.5% during the forecast period. “Hospitals” dominates the end-users segment of the market owing to the availability of highly qualified physicians. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Drug Classification (Antiemetic, Nitroglycerin, Loperamide, Antibiotics, Others), Route of Administration (Injectable, Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Ambulatory Surgical Centers, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Amicus Therapeutics, Inc. (U.S.), Alexion Pharmaceuticals, Inc. (U.S.), Sanofi (U.S.), Takeda Pharmaceutical Company Limited (Japan), Vertex Pharmaceuticals Incorporated (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), Amgen Inc. (U.S.), ELITechGroup (U.S.), GW Pharmaceuticals plc. (U.K.), Pfizer Inc. (U.S.), PerkinElmer Inc (U.S.), AutoGenomics (U.S.), Bio-Rad Laboratories, Inc. (U.S.), BioMarin (U.S.), Sarepta Therapeutics (U.S.)

Market Opportunities

  • Development of novel antiviral therapies
  • Vaccine development

Market Definition

Marburg Hemorrhagic Fever (MHF) is a rare but severe viral disease caused by the marburg virus, which belongs to the filoviridae family. MHF is characterized by a rapid onset of symptoms, including high fever, headache, malaise, muscle aches, and gastrointestinal symptoms, followed by hemorrhagic manifestations, such as bleeding from multiple organs.

Global Maraburg Hemorrhagic Fever Market Dynamics

Drivers

  • Increasing Prevalence

The rising prevalence of maraburg hemorrhagic fever globally is a significant driver for the market. Improved diagnostic techniques, increased awareness, and better access to healthcare services have contributed to identifying more cases, leading to a larger patient population.

  • Global Health Emergencies

MHF outbreaks or the occurrence of other similar infectious diseases can lead to global health emergencies, prompting increased attention and resources toward finding effective treatments for MHF. These emergencies may trigger funding allocation, research initiatives, and regulatory support for the development and availability of MHF-specific therapies.

Opportunities

  • Development of Novel Antiviral Therapies

The development of novel antiviral therapies specifically targeting MHF could present a significant opportunity. Companies involved in antiviral drug discovery and development could focus on identifying and advancing compounds that inhibit the replication of the marburg virus. Such therapies could potentially reduce morbidity and mortality rates associated with MHF.

  • Vaccine Development

The absence of an approved vaccine for MHF highlights a significant opportunity in this area. Companies specializing in vaccine research and development could invest in the creation of safe and effective vaccines against MHF. This could involve the use of novel vaccine platforms, such as viral vectors or mRNA-based technologies, to induce a protective immune response.

Restraint/Challenge

  • Lack of Standard Cure

The lack of treatments for viral hemorrhagic fever is expected to hamper the growth of the market. The treatment is costly due to the lack of FDA-approved drugs, leading to lower affordability. No current treatment can cure viral hemorrhagic fevers and immunizations exist for only two of the many viral hemorrhagic fever. These factors can impede market growth and pose barriers for market players in the forecast period from 2023 to 2030.

  • High Generic Influx

The patent expiry of most of the drugs has surfaced the way for the entry of generics into the market. The extreme use of generic medicine can hamper the demand for branded drugs, thus affecting the market.

This maraburg hemorrhagic fever market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the maraburg hemorrhagic fever Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Maraburg Hemorrhagic Fever Market Scope

The global maraburg hemorrhagic fever Market is segmented on the basis of drug classification, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Classification

  • Antiemetic
  • Nitroglycerin
  • Loperamide
  • Antibiotics
  • Others

Route of Administration

  • Injectable
  • Oral
  • Parenteral

 End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Global Maraburg Hemorrhagic Fever Market Regional Analysis/Insights

The global maraburg hemorrhagic fever market is analysed and market size insights and trends are provided by country, drug classification, route of administration, end-users and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the fever marburg hemorrhagic fever market due to the advanced medical care system and infrastructure within the region.

Asia-Pacific is expected to witness high growth during the forecast period because of the large target population in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global maraburg hemorrhagic fever market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global maraburg hemorrhagic fever market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global maraburg hemorrhagic fever Market. The data is available for historic period from 2010 to 2020.

Competitive Landscape and Maraburg Hemorrhagic Fever Market Share Analysis

The global maraburg hemorrhagic fever market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global maraburg hemorrhagic fever market.

Some of the major players operating in the global maraburg hemorrhagic fever market are

  • Amicus Therapeutics, Inc. (U.S.)
  • Alexion Pharmaceuticals, Inc. (U.S.)
  • Sanofi (U.S.)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Vertex Pharmaceuticals Incorporated (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Abbott (U.S.)
  • Amgen Inc. (U.S.)
  • ELITechGroup (U.S.)
  • GW Pharmaceuticals plc. (U.K.)
  • Pfizer Inc. (U.S.)
  • PerkinElmer Inc (U.S.)
  • AutoGenomics (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • BioMarin (U.S.)
  • Sarepta Therapeutics (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

Maraburg Hemorrhagic Fever Market will be worth USD 139.25 million by 2030.
Maraburg Hemorrhagic Fever Market growth rate is 5.5% during the forecast period.
Increasing Prevalence, Global Health Emergencies and Development of Novel Antiviral Therapies are the growth drivers of the Maraburg Hemorrhagic Fever Market.
Drug classification, route of administration, end-users and distribution channel are the factors on which the Maraburg Hemorrhagic Fever Market research is based.
Amicus Therapeutics, Inc. (U.S.), Alexion Pharmaceuticals, Inc. (U.S.), Sanofi (U.S.), Takeda Pharmaceutical Company Limited (Japan), Vertex Pharmaceuticals Incorporated (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), Amgen Inc. (U.S.), ELITechGroup (U.S.), GW Pharmaceuticals plc. (U.K.), Pfizer Inc. (U.S.), PerkinElmer Inc (U.S.), AutoGenomics (U.S.), Bio-Rad Laboratories, Inc. (U.S.), BioMarin (U.S.), Sarepta Therapeutics (U.S.) are the major companies in the Maraburg Hemorrhagic Fever Market
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials